For resectable breast cancer, pathological parameters such as tumor size, axillary lymph node involvement, histological grade, hormone receptor (HR) status, and human epidermal growth factor receptor 2 (HER2) status have been used as prognostic factors for survival. This evidence concerns the gene ERBB2 and breast cancer.